Skip to content
DataLookout
Menu

ETN-LBR-DORNCT07769684

RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Aug 1, 2026 to Apr 1, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 18 words
    • Primary completion pushed from Feb 1, 2031 to Apr 1, 2031
    • Study completion pushed from Dec 31, 2031 to Apr 1, 2032
    • Interventions: Sham electro-thumbtack needle (ETN) / sham thumbtack needle (TN) (Device), electro-thumbtack needle (ETN) / thumbtack needle (TN) (Device) to Sham electro-thumbtack needle (ETN) / sham thumbtack needle (TN) (Device), electro-thumbtack needle (ETN) / thumbtack needle (TN) (Device)
    • Site details revised at 1 of 4 sites
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Live birth rate of the first embryo transplantation in patients undergoing the first IVF-ET after treatment completion
Timeframe: At birth

Secondary (19)

Clinical pregnancy rate of the first embryo transfer in patients undergoing the first IVF-ET after treatment completion
Biochemical pregnancy rate of the first embryo transfer in patients undergoing the first IVF-ET after treatment completion
The rate of miscarriage in pregnant patients who underwent their first embryo transfer in IVF-ET after the completion of treatment
The rate of threatened miscarriage in pregnant patients who underwent their first embryo transfer in the first IVF-ET after treatment completion
Pregnancy complications in patients who underwent their first embryo transfer in IVF-ET after the completion of treatment
Show 14 moreShow less
Serum level of six sex hormones
Antral follicle count (AFC) in both ovaries
Serum level of Anti-Müllerian Hormone (AMH)
Number of oocytes and MII oocyte ratio retrieved on the first IVF-ET after treatment
Embryo status in the first IVF-ET after treatment
Depression assessment using the Zung Depression Self-Rating Scale (Zung-SDS)
Anxiety assessment using the Zung Anxiety Self-Rating Scale (Zung-SAS)
Assessment of quality of life (QOL) using MOS 36-Item Short Form Health Survey (SF-36)
Sleep quality survey using Pittsburgh Sleep Quality Index (PSQI)
Untargeted metabolomics analysis of blood
Detection of cytokines in follicular fluid collected during the first IVF-ET after treatment
Proteomic analysis of granulosa cells collected from the first IVF-ET after treatment
Untargeted metabolomics analysis of follicular fluid collected from the first IVF-ET after treatment
The health status of the offspring of the first embryo transfer in the first IVF-ET, including gestational age at birth, infant weight and height, presence of malformations, neonatal jaundice, hypoglycemia, etc

Arms and interventions

treatment groupActive comparator

Treatment of electro-thumbtack needle (ETN) / thumbtack needle (TN)

control groupSham comparator

Treatment of sham electro-thumbtack needle (ETN) / sham thumbtack needle (TN)

Devices: electro-thumbtack needle (ETN) / thumbtack needle (TN), Sham electro-thumbtack needle (ETN) / sham thumbtack needle (TN)

Sites

4 sites in 1 country